Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naive locally advanced upper aerodigestive malignancy

Cancer Investigation

Volumn 24, Issue 2, 2006, Pages 164-173

  Langer, Corey J ^a   Duffy, Karen ^a   Horwitz, Eric M ^a   Litwin, Samuel ^d   Rosvold, Elizabeth ^b   Schol, Jessie ^c   Keenan, Eileen ^c   Nicolaou, Nicos ^a   Friedman, Craig D ^a   Ridge, John A ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b ST FRANCIS MEDICAL CENTER   (United States)

^c Protocol Office   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL;

ADULT; AGED; ANEMIA; ARTICLE; BONE NECROSIS; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEHYDRATION; DIARRHEA; DISEASE EXACERBATION; ESOPHAGITIS; FATIGUE; FEMALE; FEVER; HEAD AND NECK CARCINOMA; HEART INFARCTION; HUMAN; MALE; MAXIMUM TOLERATED DOSE; MUCOSA INFLAMMATION; MUCUS GLAND; NAUSEA; NEUROPATHY; NEUTROPENIA; OTOTOXICITY; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SEROMA; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; STRIDOR; THROMBOCYTOPENIA; TRACHEOBRONCHITIS; TRISMUS; TUMOR GROWTH; TUMOR RECURRENCE; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; EAR NEOPLASMS; FEMALE; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; PACLITAXEL; RADIATION-SENSITIZING AGENTS; SALIVARY GLAND NEOPLASMS; SURVIVAL ANALYSIS;

EID: 33645004565     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900500524421     Document Type: Article

References (32)

1. Al-Sarraf, M. Head and neck cancer: chemotherapy concepts. Semin. Oncol. 1988, 15, 70-85.
2. Forastiere, A.A.; Metch, B.; Schuller, D.E.; et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous cell carcinoma of the head and neck. A Southwest Oncology Group Study. J. Clin. Oncol. 1992, 10, 1245-1251.
3. Jacobs, C.; Lyman, G.; Velez-Garcia, E.; et al. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J. Clin. Oncol. 1992, 10, 257-263.
4. Coughlin, C.T.; Richmond, R.C. Biologic and clinical development of cisplatin combined with radiation: concepts, utility, projections for new trials, and the emergence of carboplatin. Semin. Oncol. 1989, (Suppl. 6), 31.
5. Tischler, R.B.; Geard, C.R.; Hall, E.J.; et al.Taxol sensitizes human astrocytoma cells to radiation. Cancer Res. 992, 52, 3495-3497.
6. Choy, H.; Rodriquez, F.F.; Koester, S.; et al. Investigation of taxol as a potential radiation sensitizer. Cancer 1993, 71, 3774-3778.
7. Liebmann, J.; Cook, J.A.; Fisher, J; et al. In vitro studies of taxol as a radiation sensitizer in human tumor cells. J. Natl. Cancer Inst. 994, 86, 441-446.
8. Choy, H.; Browne, M.J. Paclitaxel as a radiation sensitizer in non-small cell lung cancer. Semin. Oncol. 1995, 22 (3), (Suppl. 6), 70-74.
9. Schaake-Koning, C.; Vanden Bogaert, W.; Dalesio, O.; et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N. Engl. J. Med. 1992, 326, 524-530.
10. Hazuka, M.; Crowley, J.; Bunn, P.; et al. Concurrent daily low dose cisplatin (LDCP) combined with chest irradiation (RT) in locally advanced non-small cell lung cancer: preliminary results of a SWOG study. Proc. Am. Soc. Clin. Oncol. 1992, 11, 295.
11. Adelstein, D.; Adams, G.L.; Li, Y.; et al. Phase III comparison of standard radiation therapy versus radiation plus concurrent cisplatin versus split course RT plus concurrent cisplatin and 5-fluorouracil in patients with unresectable squamous cell head and neck cancer: an intergroup study. Proc. Am. Soc. Clin. Oncol. 2000, A-1624.
12. Forastiere, A. A.; et al. Use of paclitaxel in squamous cell carcinoma of the head and neck. Proc. Am. Soc. Clin. Oncol. 1995, 22 (3), (Suppl 6), 70-74.
13. Chang, A.; Kim, K.; Glick, J.; et al. Phase II study of paclitaxel in patients with stage IV non-small cell lung cancer: the Eastern Cooperative Group (ECOG) results. J. Natl. Cancer. Inst. 1993, 85, 388-393.
14. Murphy, W.R.; Winn, R.T.; Rossella, F.V.; et al. A phase II study of paclitaxel (NSC 125973) in patients with non-small cell I ung cancer. J. Natl. Cancer Inst. 1993, 85, 384-387.
15. Gatzmeier, U.; Pawel, J.R; Heckmayer, M.; Neuhass, R.; Schluter, I. Phase II study with paclitaxel in advanced, inoperable non-small cell lung cancer (NSCLC). The European experience. Lung Cancer 1994, 11 (Suppl 2), 236.
16. Vokes, E.E.; Haraf, D.J.; Mick, R.; et al. Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer. J. Clin. Oncol. 1994; 12, 2351-2359.
17. Spencer, S.; Wheeler, R.; Meredith, R.; Petus, G.; Robert, F.; Kim, R.; Walter, M. Simultaneous hydroxyurea, 5-fluorouracil and high dose b.i.d. irradiation in previously irradiated patients with recurrent squamous cell cancer of the head and neck. Third International Conference on Head and Neck Cancer, San Francisco, CA, July 1992.
18. Vokes, E.E.; Moormeier, J.A.; Ratain, M.J.; et al. 5-fluorouracil, leucovorin, hydroxyurea and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study. Cancer Chemother. Pharmacol. 1992, 29, 178-184.
19. Bunn, P.A.; Crowley, J.; Hazuka, M.; et al. The role of GM-CSF in limited stage SCLC: a randomized phase III study of the Southwest Oncology Group (SWOG). Proc. Am. Soc. Clin. Oncol. 1992, 11, A-974.
20. Momin, F.; Kraut, M.; Lattin, P.; et al. Thrombocytopenia in patients receiving chemoradiotherapy and G-CSF for locally advanced non-small cell lung cancer (NSCLC). Proc. Am. Soc. Clin. Oncol. 1992, 11, A-983.
21. Crawford, J.; Ozer, H.; Stoller, R.; et al. Reduction by colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lung cancer. N. Engl. J. Med. 1991, 325, 164-170.
22. Langlois, D.; Eschwege, F.; Kramar, A.; Richard, J.M. Re-irradiation of head and neck cancers. Radiother. Oncol. 1985, 3, 27-33.
23. Pomp, J.; Levendag, P.C.; van Putten, W.L.J. Re-irradiation of recurrent tumors in the head and neck. Am J. Clin. Oncol. 1988, 11, 543-549.
24. Skolyszewski, J.; Korzeniowski, S.; Reinfuss, M. The re-irradiation of recurrences of head and neck cancer. Br. J. Radiol. 1980, 53, 462-465.
25. Stevens, K.R.; Britsch, A.; Moss, W.T. High-dose re-irradiation of head and neck cancer with curative intent. Int. J. Radiat. Oncol. Biol. Phys. 1994, 29, 687-698.
26. Emami, B.; Marks, J.E. Re-treatment of recurrent carcinoma of the head and neck by after loading interstitial 192IR implant. Laryngoscope 1983, 93, 1345-1347.
27. Mazeron, J.J.; Langlois, D.; Glaubiger, D.; Huart, J.; Martin, M. Salvage irradiation of oropharyngeal cancers using iridium 192 wire implants: 5-year results of 70 cases. Int. J. Radiat. Oncol. Biol. Phys. 1987, 13, 957-962.
28. Puthawala, A.A.; Syed, A.M.N. Interstitial re-irradiation for recurrent and/or persistent head and neck cancers. Int. J. Radiat. Oncol. Biol. Phys. 1987, 13, 1113-1114.
29. RTOG 9911. Phase II study of concurrent split course hyperfractionated XRT, cisplatin and paclitaxel in previously irradiated squamous cell carcinoma of the head and neck.
30. Hendry, J.H.; Rosenberg, I.; Greene, D.; Stewart, J.G. Reirradiation of rat tails to necrosis at six months after treatment with a tolerancy dose of x-ray or neutrons. Br. J. Radiol. 1977, 50, 567-573.
31. Brown, J.M.; Probert, J.C. Early and late radiation changes following a second course of irradiation. Radiology 1975, 115, 711-716.
32. Jeremic, B.; Djuric, L.; Mijatovic, L. Incidence of radiation myelitis of the cervical spine at doses of 5500 cGy or greater. Cancer 1991, 68, 2138-2141.